메뉴 건너뛰기




Volumn 57, Issue 4, 2016, Pages 831-839

Fibroblast growth factor receptor 1 overexpression is associated with poor survival in patients with resected muscle invasive urothelial carcinoma

Author keywords

Cystectomy; Prognosis; Receptor tyrosine kinases; Urinary bladder neoplasms

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; FGFR1 PROTEIN, HUMAN; FGFR3 PROTEIN, HUMAN;

EID: 84969135194     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2016.57.4.831     Document Type: Article
Times cited : (17)

References (25)
  • 2
    • 33644868287 scopus 로고    scopus 로고
    • Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
    • Knowles MA. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 2006;27:361-73.
    • (2006) Carcinogenesis , vol.27 , pp. 361-373
    • Knowles, M.A.1
  • 3
    • 25444467767 scopus 로고    scopus 로고
    • Urothelial tumorigenesis: A tale of divergent pathways
    • Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005;5:713-25.
    • (2005) Nat Rev Cancer , vol.5 , pp. 713-725
    • Wu, X.R.1
  • 4
    • 0035254218 scopus 로고    scopus 로고
    • Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1, 054 patients
    • Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 2001;19:666-75.
    • (2001) J Clin Oncol , vol.19 , pp. 666-675
    • Stein, J.P.1    Lieskovsky, G.2    Cote, R.3    Groshen, S.4    Feng, A.C.5    Boyd, S.6
  • 5
    • 0033857218 scopus 로고    scopus 로고
    • Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study
    • von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000;18:3068-77.
    • (2000) J Clin Oncol , vol.18 , pp. 3068-3077
    • von der Maase, H.1    Hansen, S.W.2    Roberts, J.T.3    Dogliotti, L.4    Oliver, T.5    Moore, M.J.6
  • 6
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92.
    • (2001) N Engl J Med , vol.344 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3    Fuchs, H.4    Paton, V.5    Bajamonde, A.6
  • 8
    • 77956262693 scopus 로고    scopus 로고
    • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
    • Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687-97.
    • (2010) Lancet , vol.376 , pp. 687-697
    • Bang, Y.J.1    Van Cutsem, E.2    Feyereislova, A.3    Chung, H.C.4    Shen, L.5    Sawaki, A.6
  • 9
    • 77951471947 scopus 로고    scopus 로고
    • Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: Results in 1005 patients
    • Laé M, Couturier J, Oudard S, Radvanyi F, Beuzeboc P, Vieillefond A. Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients. Ann Oncol 2010;21:815-9.
    • (2010) Ann Oncol , vol.21 , pp. 815-819
    • Laé, M.1    Couturier, J.2    Oudard, S.3    Radvanyi, F.4    Beuzeboc, P.5    Vieillefond, A.6
  • 11
    • 0029655413 scopus 로고    scopus 로고
    • CerbB-2 in bladder cancer: Molecular biology, correlation with epidermal growth factor receptors and prognostic value
    • Mellon JK, Lunec J, Wright C, Horne CH, Kelly P, Neal DE. CerbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J Urol 1996; 155:321-6.
    • (1996) J Urol , vol.155 , pp. 321-326
    • Mellon, J.K.1    Lunec, J.2    Wright, C.3    Horne, C.H.4    Kelly, P.5    Neal, D.E.6
  • 13
    • 0032519575 scopus 로고    scopus 로고
    • Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2
    • Vollmer RT, Humphrey PA, Swanson PE, Wick MR, Hudson ML. Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2. Cancer 1998;82:715-23.
    • (1998) Cancer , vol.82 , pp. 715-723
    • Vollmer, R.T.1    Humphrey, P.A.2    Swanson, P.E.3    Wick, M.R.4    Hudson, M.L.5
  • 14
    • 52649176386 scopus 로고    scopus 로고
    • Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy
    • Kolla SB, Seth A, Singh MK, Gupta NP, Hemal AK, Dogra PN, et al. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy. Int Urol Nephrol 2008;40:321-7.
    • (2008) Int Urol Nephrol , vol.40 , pp. 321-327
    • Kolla, S.B.1    Seth, A.2    Singh, M.K.3    Gupta, N.P.4    Hemal, A.K.5    Dogra, P.N.6
  • 15
    • 14644394929 scopus 로고    scopus 로고
    • Cell responses to FGFR3 signalling: Growth, differentiation and apoptosis
    • L'Hôte CG, Knowles MA. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 2005;304:417-31.
    • (2005) Exp Cell Res , vol.304 , pp. 417-431
    • L'Hôte, C.G.1    Knowles, M.A.2
  • 16
    • 84864917826 scopus 로고    scopus 로고
    • A decade of FGF receptor research in bladder cancer: Past, present, and future challenges
    • di Martino E, Tomlinson DC, Knowles MA. A decade of FGF receptor research in bladder cancer: past, present, and future challenges. Adv Urol 2012;2012:429213.
    • (2012) Adv Urol , vol.2012
    • di Martino, E.1    Tomlinson, D.C.2    Knowles, M.A.3
  • 17
    • 0035081241 scopus 로고    scopus 로고
    • Fibroblast growth factors
    • REVIEWS3005
    • Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001;2: REVIEWS3005.
    • (2001) Genome Biol , vol.2
    • Ornitz, D.M.1    Itoh, N.2
  • 18
    • 34548407864 scopus 로고    scopus 로고
    • FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
    • Tomlinson DC, Baldo O, Harnden P, Knowles MA. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J Pathol 2007;213:91-8.
    • (2007) J Pathol , vol.213 , pp. 91-98
    • Tomlinson, D.C.1    Baldo, O.2    Harnden, P.3    Knowles, M.A.4
  • 19
    • 78650875209 scopus 로고    scopus 로고
    • Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
    • Lamont FR, Tomlinson DC, Cooper PA, Shnyder SD, Chester JD, Knowles MA. Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo. Br J Cancer 2011;104:75-82.
    • (2011) Br J Cancer , vol.104 , pp. 75-82
    • Lamont, F.R.1    Tomlinson, D.C.2    Cooper, P.A.3    Shnyder, S.D.4    Chester, J.D.5    Knowles, M.A.6
  • 20
    • 66349120144 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer
    • Tomlinson DC, Lamont FR, Shnyder SD, Knowles MA. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. Cancer Res 2009;69:4613-20.
    • (2009) Cancer Res , vol.69 , pp. 4613-4620
    • Tomlinson, D.C.1    Lamont, F.R.2    Shnyder, S.D.3    Knowles, M.A.4
  • 22
    • 84874888512 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer
    • Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, et al. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. J Clin Oncol 2013;31:731-7.
    • (2013) J Clin Oncol , vol.31 , pp. 731-737
    • Kim, H.R.1    Kim, D.J.2    Kang, D.R.3    Lee, J.G.4    Lim, S.M.5    Lee, C.Y.6
  • 23
    • 84866516574 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
    • Jung EJ, Jung EJ, Min SY, Kim MA, Kim WH. Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma. Hum Pathol 2012;43:1559-66.
    • (2012) Hum Pathol , vol.43 , pp. 1559-1566
    • Jung, E.J.1    Jung, E.J.2    Min, S.Y.3    Kim, M.A.4    Kim, W.H.5
  • 24
    • 84864509652 scopus 로고    scopus 로고
    • FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
    • Jang M, Kim E, Choi Y, Lee H, Kim Y, Kim J, et al. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma. Breast Cancer Res 2012;14:R115.
    • (2012) Breast Cancer Res , vol.14
    • Jang, M.1    Kim, E.2    Choi, Y.3    Lee, H.4    Kim, Y.5    Kim, J.6
  • 25
    • 78149318726 scopus 로고    scopus 로고
    • Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer
    • Tomlinson DC, Knowles MA. Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. Am J Pathol 2010;177:2379-86.
    • (2010) Am J Pathol , vol.177 , pp. 2379-2386
    • Tomlinson, D.C.1    Knowles, M.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.